Advertisement

Topics

Analysts' Weekly Ratings Updates for Bristol-Myers Squibb

00:08 EDT 23 Sep 2016 | Topix

They now have a "buy" rating on the stock. 9/12/2016 - Bristol-Myers Squibb had its "hold" rating reaffirmed by analysts at Jefferies Group.

Original Article: Analysts' Weekly Ratings Updates for Bristol-Myers Squibb

NEXT ARTICLE

More From BioPortfolio on "Analysts' Weekly Ratings Updates for Bristol-Myers Squibb"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...